drugset / Trial / NCT00620867

Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (United States)

NCT00620867

Phase 4 Completed 393 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the efficacy and safety of celecoxib versus ibuprofen in subjects with osteoarthritis (OA) of the knee.

Timeline

Start
2002-10
Primary completion
2003-03
Completion
2003-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg Oral
Subject Ibuprofen Small molecule 800 mg Oral

Indications